ATG5 as a Serum Marker of Autophagy in Psoriatic Patient
NCT05279638 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2022-03-15
Summary
it will be of interest to know the ATG 5 as a serum marker of autophagy in serum of psoriasis vulgairs patients and explore its relationship with psoriasis severity.
Conditions
- Psoriasis Vulgaris
- Autophagy
Interventions
- DIAGNOSTIC_TEST
-
serum ATG5
This kit is used to assay the Autophagy protein 5(ATG5) in the sample of human's serum, blood plasma, and other related tissue Liquid
Sponsors & Collaborators
-
Sohag University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-02-01
- Primary Completion
- 2023-02-01
- Completion
- 2024-01-01
Countries
- Egypt
Study Locations
More Related Trials
-
CD4+ T Cells and S100A7 Epression in Normal and Psoriatic Skin: A Histological and Histochemical Study
NCT06050330 ·Status: COMPLETED ·Phase: NA
-
Comparison Between Oral Methotrexate and Tofacitinib in Chronic Plaque Psoriasis
NCT07261306 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
A Study of Treatment Patterns and Clinical Outcomes of Psoriasis in Japan
NCT04826536 ·Status: COMPLETED
-
Card14gene (rs34367357 ) Polymorphism in Egyptian Psoriatic and Psoriatic Arthritis Patient
NCT06870500 ·Status: RECRUITING ·Phase: NA
-
Study of Efficacy and Safety of Investigational Treatment in Patients With Nail Psoriasis
NCT05072886 ·Status: UNKNOWN ·Phase: PHASE1
-
Microbiome and Clinical Response to Probiotics and Methotrexate in Early Psoriasis: a Pilot Study
NCT07169019 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Safety and Tolerability of Repeat Courses of IM Alefacept
NCT00794807 ·Status: COMPLETED ·Phase: PHASE4
-
Excimer Light in Psoriasis
NCT05283876 ·Status: COMPLETED ·Phase: NA
-
Nd:YAG Laser and Radiofrequency in Treatment of Fingernail Psoriasis
NCT05695833 ·Status: UNKNOWN ·Phase: NA
-
Physician- vs Questionnaire-Based Screening for Psoriatic Arthritis in Psoriasis
NCT07298265 ·Status: RECRUITING
-
Estimation of Level of ERAP1 Expression in Lesional and Non Lesional Skin of Psoraitic Patients and Healthy Controls.
NCT03767114 ·Status: COMPLETED ·Phase: NA
-
Evaluation The Effect of NB-UVB and Methotrexate on The Level of Serum Gelsolin in Psoriatic Patients
NCT06712238 ·Status: RECRUITING ·Phase: NA
-
Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
NCT00477191 ·Status: TERMINATED ·Phase: NA
-
Omentin-1 Level in Psoriatic Patients Treated With Narrowband Ultraviolet B Phototherapy Versus Acitretin
NCT05203354 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Acitretin Versus Narrowband Ultraviolet B on Neopterin Level in Psoriatic Patients .
NCT05401006 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Assess the Severity of Psoriasis in Brazilians Participants With Chronic Plaque-type Psoriasis
NCT02274363 ·Status: COMPLETED
-
Evaluation of the Effect of Narrowband UVB Versus Methotrexate on Serum Chitotriosidase Level in Psoriasis
NCT05427175 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Efficacy of BFH772 in Psoriasis Patients
NCT00987870 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Effect of Psoriatic Arthritis on Female Sexual Dysfunction
NCT06370221 ·Status: NOT_YET_RECRUITING
-
AGN-242428 in the Treatment of Plaque Psoriasis
NCT03339999 ·Status: TERMINATED ·Phase: PHASE2
-
Intralesional Injection Of Methotrexate Versus Triamcinolone Acetonid In Treatment Of Localized Psoriasis
NCT05408208 ·Status: UNKNOWN ·Phase: NA
-
MTX-related Liver Toxicity in Psoriasis Patients, Using Ultrasound-based Techniques as a Diagnostic Tool
NCT04168619 ·Status: UNKNOWN
-
A Study of SHR-1314 in Healthy Subjects
NCT02934412 ·Status: COMPLETED ·Phase: PHASE1
-
Using Acetylcysteine and Vitamin E With Psoriasis Vulgaris
NCT05906498 ·Status: UNKNOWN ·Phase: PHASE3
-
Study Evaluating the Efficacy and Safety of Triptergium Wilfordii and Acitretin in Psoriasis Vulgaris - CHINA201002016-2
NCT01443338 ·Status: UNKNOWN ·Phase: PHASE4